Rina Kim

Rina Kim

Auto-generated profile, based on publicly available information

Rina Kim

Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2022 in Nature
Verified
Journal Article
Closed access
PDF file
RKRina Kim
Rina Kim
AHAyumi Hashimoto
Ayumi Hashimoto
NMNune Markosyan
Nune Markosyan
VTVladimir A. Tyurin
Vladimir A. Tyurin
YTYulia Y. Tyurina
Yulia Y. Tyurina
DGDmitry Gabrilovich
Dmitry Gabrilovich

1 December 2017 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
Nicolas CuburuNicolas Cuburu
Nicolas Cuburu
SKSelina Khan
Selina Khan
CTCynthia D. Thompson
Cynthia D. Thompson
RKRina Kim
Rina Kim
JVJort Vellinga
Jort Vellinga
JSJohn T. Schiller
John T. Schiller

15 February 2019 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
Nicolas CuburuNicolas Cuburu
Nicolas Cuburu
RKRina Kim
Rina Kim
GGGeoffrey C. Guittard
Geoffrey C. Guittard
CTCynthia D. Thompson
Cynthia D. Thompson
PDPatricia Day
Patricia Day
JSJohn T Schiller
John T Schiller
Recent insight into the mechanisms of induction of tissue-resident memory (TRM) CD8+ T cells (CD8+ TRM) enables the development of novel vaccine strategies against sexually transmitted infections. To maximize both systemic and genital intraepithelial CD8+ T cells against vaccine Ags, we assessed combinations of i.m. and intravaginal routes in heterologous prime-boost immunization regimens with unrelated viral vectors. Only i.m. prime followed by intravaginal boost induced concomitant strong systemic and intraepithelial genital-resident CD8+ T cell responses. Intravaginal boost with vectors expressing vaccine Ags was far superior to intravaginal instillation of CXCR3 chemokine receptor ligands or TLR 3, 7, and 9 agonists to recruit and increase the pool of cervicovaginal CD8+ TRM. Transient Ag presentation increased trafficking of cognate and bystander circulating activated, but not naive, CD8+ T cells into the genital tract and induced in situ proliferation and differentiation of cognate CD8+ TRM. Secondary genital CD8+ TRM were induced in the absence of CD4+ T cell help and shared a similar TCR repertoire with systemic CD8+ T cells. This prime-pull-amplify approach elicited systemic and genital CD8+ T cell responses against high-risk human papillomavirus type 16 E7 oncoprotein and conferred CD8-mediated protection to a vaccinia virus genital challenge. These results underscore the importance of the delivery route of nonreplicating vectors in prime-boost immunization to shape the tissue distribution of CD8+ T cell responses. In this context, the importance of local Ag presentation to elicit genital CD8+ TRM provides a rationale to develop novel vaccines against sexually transmitted infections and to treat human papillomavirus neoplasia.